I agree, not worth puting a target price on it, we do not want another Patersons type report with a target of .55 whilst they are selling at .11 do we.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025